U.S. Controls Hamper Trade With Allies

WASHINGTON—The Japanese buy infrared, optical lasers from the American firm of Spectra-Physics for the cutting, welding and heat treating of various manufactured products. But each time any of its lasers need servicing or spare parts, Spectra-Physics has to navigate the slow and complex U.S. export licensing procedure that was created for another purpose, namely, to ensure that certain types of advanced technology do not pass to the Soviet Union and its allies. Although the San Jose-based

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Although the San Jose-based company usually manages to satisfy its customers, said President Herbert Dwight Jr., the export controls have hurt its relationship with some clients and cost it additional sales in Japan and throughout Europe. "I support the need to deny the Soviets access to critical technology," said Dwight, an electrical engineer who founded the company in 1961. "But by doing it unilaterally we're shooting ourselves in the foot. And in the process we're restricting trade with our Western allies."

Last month a panel of the U.S. National Academy of Sciences concluded that the present export controls are not working as they were meant to because they "fail to promote both military security and economic vitality." The panel, on which Dwight served, said small and medium businesses (SpectraPhysics had annual sales last year of $220 million and employs 2,500 people) have been particularly hard-hit because their size makes them ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies